Blood glucose monitoring market seen reaching $24.68 billion by 2030

The global blood glucose monitoring systems market is projected to grow from $17.66 billion in 2025 to $24.68 billion by 2030, driven by rising diabetes cases and wider use of continuous and connected monitoring tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Blood glucose monitoring is central to diabetes management, and demand is rising as more people need tools to track and control blood sugar. - The market forecast points to sustained growth in devices that support self-monitoring, remote care and continuous glucose tracking. - The shift matters for patients, providers and device makers as diabetes care moves toward more connected and less invasive monitoring.

What happened: - The Business Research Company said the blood glucose monitoring systems market will grow from $17.66 billion in 2025 to $19 billion in 2026. - The market is projected to reach $24.68 billion by 2030. - The report puts the market at a 7.6% compound annual growth rate in the historical period and 6.8% in the forecast period. - The analysis was published July 29, 2026, from London. - A free sample of the report is available here.

The details: - Blood glucose monitoring systems measure and display blood glucose concentration. - The devices typically include a meter and disposable test strips. - Users usually apply a small blood sample, often from a fingertip, for analysis. - The systems help people track blood sugar levels and avoid serious complications linked to diabetes. - Growth in the historical period was driven by rising global diabetes prevalence, greater awareness of self-monitoring, early commercialization of invasive glucose meters and test strips, and expansion of home healthcare and outpatient diabetes services. - Forecast growth is tied to demand for continuous glucose monitoring and flash monitoring systems. - Wider adoption of wearable and implantable devices is also expected to support growth. - Remote and connected diabetes management tools are becoming more important in the market. - Non-invasive glucose sensing technologies are advancing. - The market is also shifting toward minimally invasive devices, portable systems and self-monitoring products. - Applications now span type 1, type 2 and gestational diabetes. - The full report is available here. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific will be the fastest-growing region during the forecast period. - The geographic scope also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast reflects a broader move from basic glucose testing toward continuous, wearable and connected disease management. - The strongest growth in Asia-Pacific suggests rising demand is spreading beyond mature healthcare markets. - The expansion in non-invasive and minimally invasive technologies signals pressure to make monitoring easier and less burdensome for patients.

What's next: - The market outlook points to further adoption of CGM, flash monitoring and connected diabetes tools through 2030. - Continued growth in diabetes prevalence will likely keep pressure on monitoring device makers and healthcare systems. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics and updated trend analysis.

The bottom line: - Blood glucose monitoring remains a fast-growing diabetes care market, with the biggest opportunity shifting toward connected, wearable and less invasive technologies.